Stock listing

NASDAQ:SESN Sesen Bio Inc Stock

Follow Sesen Bio Inc into a list and get an email when it puts out news.

Delisted NASDAQ:SESN no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.

Ticker
NASDAQ:SESN
Asset type
Stock
Exchange
NASDAQ
Currency
USD

Sesen Bio Inc on 6ix

Decks
34 decks · latest Apr 10, 2024

Decks

DeckKindSlidesDate
Carisma Therapeutics — Technical Presentation (April 2024)Technical9 slidesApr 10, 2024
Carisma Therapeutics — CAR-TCR Summit 2023Conference20 slidesSep 1, 2023
Merger or Acquisition (February 2023)Merger or acquisition17 slidesFeb 2, 2023
Merger or Acquisition (December 2022)Merger or acquisition24 slidesDec 12, 2022
Merger or Acquisition (September 2022)Merger or acquisition26 slidesSep 27, 2022
Technical Presentation (September 2021)Technical17 slidesSep 10, 2021
Jefferies Virtual Healthcare Conference 2021Conference74 slidesJun 4, 2021
Q1 2021 Earnings PresentationEarnings76 slidesMay 10, 2021
Corporate Update (March 2021)Corporate update84 slidesMar 15, 2021
Investor Presentation (March 2021)Investor deck82 slidesMar 1, 2021
All 34 decks
DeckKindSlidesDate
Corporate Update (January 2021)Corporate update82 slidesJan 11, 2021
Q3 2020 Earnings PresentationEarnings84 slidesNov 9, 2020
Corporate Update (October 2020)Corporate update77 slidesOct 13, 2020
H.C. Wainwright 22nd Annual Global Investment Conference (September 2020)Conference74 slidesSep 15, 2020
2020 Canaccord Genuity Global Growth ConferenceConference77 slidesAug 5, 2020
Corporate Update (July 2020)Corporate update77 slidesJul 31, 2020
2020 Jefferies Healthcare ConferenceConference69 slidesJun 2, 2020
Corporate Update (May 2020)Corporate update68 slidesMay 11, 2020
Corporate Update (March 2020)Corporate update62 slidesMar 16, 2020
J.P. Morgan 38th Annual Healthcare Conference 2020Conference67 slidesJan 10, 2020
Corporate Update (December 2019)Corporate update68 slidesDec 16, 2019
Q3 2019 Earnings PresentationEarnings66 slidesNov 8, 2019
H.C. Wainwright 21st Annual Global Investment Conference (September 2019)Conference62 slidesSep 10, 2019
2019 Canaccord Genuity Global Growth ConferenceConference53 slidesAug 7, 2019
Corporate Update (June 2019)Corporate update47 slidesJun 10, 2019
Q1 2019 Earnings PresentationEarnings45 slidesMay 13, 2019
Corporate Update (March 2019)Corporate update36 slidesMar 4, 2019
Corporate Update (January 2019)Corporate update24 slidesJan 4, 2019
Technical Presentation (January 2019)Technical22 slidesJan 3, 2019
American Urological Association 2018 Annual MeetingConference14 slidesMay 21, 2018
Eleven Biotherapeutics — Investor Presentation (October 2017)Investor deck39 slidesOct 20, 2017
Eleven Biotherapeutics — IPO Roadshow (October 2017)IPO roadshow39 slidesOct 20, 2017
Eleven Biotherapeutics — Investor Presentation (May 2017)Investor deck34 slidesMay 1, 2017
Eleven Biotherapeutics — Investor Presentation (January 2017)Investor deck42 slidesJan 6, 2017

Open Decks

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Wendy L Dixon
Other companies: Zevra Therapeutics, Inc. (Director · Since at least Apr 25, 2023); Iovance Biotherapeutics, Inc. (Director · Jun 10, 2022 – Jun 10, 2022 · Past); Black Diamond Therapeutics, Inc. (Director · Apr 6, 2022 – Mar 15, 2024 · Past); Arvinas, Inc. (Director · Jun 29, 2020 – Jun 15, 2023 · Past); Voyager Therapeutics, Inc. (Director · Jan 1, 2017 – Jun 4, 2020 · Past); Eleven Biotherapeutics Inc (Director · Oct 22, 2014 – May 19, 2017 · Past); Bluebird bio Inc (Director · Jun 18, 2013 – Nov 11, 2021 · Past); Ardea Biosciences Inc (Director · Apr 6, 2011 – Jun 19, 2012 · Past); Alkermes plc (Director · Jan 13, 2011 – Jun 14, 2022 · Past); Furiex Pharmaceuticals Inc (Director · May 27, 2010 – Jul 2, 2014 · Past); Incyte Corporation (Director · May 21, 2010 – Mar 31, 2022 · Past); Orexigen Therapeutics Inc (Director · Apr 20, 2010 – Jun 9, 2015 · Past); Dentsply Sirona Inc. (Director · Jul 31, 2007 – Jul 8, 2010 · Past); Bristol-Myers Squibb Company (CMO & Pres, Global Marketing · Mar 7, 2006 – May 22, 2006 · Past)
Director · Jun 12, 2018 – Jun 19, 2019 · Past
Daniel Lynch
Other companies: TCGX Acquisition Corp. (Chairman of the TriGemX Bio Board of Directors · Since Nov 9, 2026); SpringWorks Therapeutics Inc (Director · Since at least Sep 12, 2019); Xilio Therapeutics, Inc. (Director · Oct 21, 2021 – Oct 21, 2021 · Past); 2Seventy Bio Inc (Director · Oct 18, 2021 – Jun 13, 2023 · Past); Omega Alpha SPAC (Director · Jan 6, 2021 – Jan 6, 2021 · Past); Translate Bio Inc (Director · Jun 27, 2018 – Dec 31, 2020 · Past); Surface Oncology Inc (Director · Apr 18, 2018 – Jun 10, 2020 · Past); Blueprint Medicines Corp (Director · Apr 30, 2015 – Jun 24, 2020 · Past); Eleven Biotherapeutics Inc (Director · Feb 5, 2014 – May 19, 2017 · Past); BIND Therapeutics Inc (Director · Sep 19, 2013 – Jun 9, 2015 · Past); Bluebird bio Inc (Director · Jun 18, 2013 – Nov 11, 2021 · Past)
Director · Jun 12, 2018 – Jun 19, 2019 · Past
Jane Pritchett Henderson
Other companies: CARGO Therapeutics, Inc. (Director · Since at least Jun 3, 2024); Apogee Therapeutics, Inc. (Chief Financial Officer · Since at least Jul 13, 2023); Akero Therapeutics Inc (Director · Since at least Jun 19, 2019); Invivyd, Inc. (Chief Financial Officer · Aug 5, 2021 – Jan 30, 2022 · Past); IVERIC bio Inc (Director · Jan 13, 2018 – Jul 11, 2023 · Past); Voyager Therapeutics, Inc. (Sr. V.P. & CFO, Corp. Dev. · Jan 1, 2017 – Mar 22, 2018 · Past); Eleven Biotherapeutics Inc (Director · Feb 5, 2014 – May 19, 2017 · Past)
Director · Jun 12, 2018 – May 3, 2021 · Past
Richard F Fitzgerald
Other companies: 22nd Century Group, Inc (Chief Financial Officer · Nov 15, 2021 – Mar 21, 2022 · Past); Nauticus Robotics, Inc. (Chief Financial Officer · Jul 14, 2021 – Jul 14, 2021 · Past); Immunome, Inc. (Chief Financial Officer · Oct 1, 2020 – Oct 1, 2020 · Past); Eleven Biotherapeutics Inc (Chief Financial Officer · Oct 20, 2017 – Apr 9, 2018 · Past); PAVmed Inc. (CFO and Secretary · Jan 29, 2016 – Jun 1, 2016 · Past); TechPrecision Corporation (Chief Financial Officer · Jun 13, 2013 – Aug 12, 2015 · Past)
Chief Financial Officer · Feb 21, 2019 – Feb 21, 2019 · Past
Jason Keyes
Other companies: BlossomHill Therapeutics, Inc. (Executive Vice President and Chief Financial Officer · Since at least Aug 6, 2026); Actuate Therapeutics, Inc. (Director · Since at least Aug 12, 2024); Equillium, Inc. (Chief Financial Officer · Oct 11, 2018 – Feb 14, 2025 · Past); Orexigen Therapeutics Inc (EVP, Chief Financial Officer · Jun 8, 2016 – Oct 13, 2017 · Past)
Director · Feb 24, 2020 – Jun 22, 2022 · Past
Dennis Kim
Other companies: Skye Bioscience, Inc. (Chief Medical Officer · Aug 21, 2019 – Aug 7, 2020 · Past); Larimar Therapeutics, Inc. (Chief Medical Officer · Jun 18, 2014 – Jan 22, 2019 · Past); Orexigen Therapeutics Inc (Sr. VP, Corporate Development · Feb 27, 2009 – Apr 23, 2009 · Past)
Chief Medical Officer · Dec 3, 2018 – Dec 3, 2018 · Past
Paul G Chaney
Other companies: Kiora Pharmaceuticals, Inc. (Director · Feb 12, 2015 – Mar 3, 2023 · Past); Eleven Biotherapeutics Inc (Director · Feb 27, 2014 – May 19, 2017 · Past); Osi Pharmaceuticals Inc (Exec. VP & Pres. (OSI) Eyetech · May 1, 2006 – May 1, 2006 · Past)
Director · Jun 12, 2018 – Jun 12, 2018 · Past
Peter Honig
Other companies: Karyopharm Therapeutics Inc. (Director · Dec 3, 2021 – May 24, 2023 · Past); Eiger Biopharmaceuticals Inc (Director · Mar 2, 2014 – Jun 4, 2015 · Past); Orexigen Therapeutics Inc (Director · Jun 5, 2013 – Jul 14, 2017 · Past)
Director · Jul 20, 2021 – Jun 22, 2022 · Past
Carrie L. Bourdow
Other companies: Trevena, Inc. (President and Chief Executive Officer · Since at least May 4, 2015); Nabriva Therapeutics AG (Director · Jun 23, 2017 – Aug 1, 2022 · Past)
Director · Feb 24, 2020 – Jun 22, 2022 · Past
Jay S. Duker
Other companies: EyePoint, Inc. (President & CEO and Board Director · Since at least Sep 26, 2016); Eleven Biotherapeutics Inc (Director · Jan 20, 2015 – May 19, 2017 · Past)
Director · Jun 12, 2018 – Jun 22, 2022 · Past
All 22 people
PersonSeat
Stephen A Hurly
Other companies: LAVA Therapeutics NV (Chief Executive Officer, Director · Since at least Jan 1, 2025); Eleven Biotherapeutics Inc (President and CEO, Director · Sep 20, 2016 – Apr 9, 2018 · Past)
President and CEO, Director · Jun 12, 2018 – Jun 12, 2018 · Past
Abbie Celniker
Other companies: Eleven Biotherapeutics Inc (Director · Jun 15, 2016 – May 19, 2017 · Past)
Director · Jun 12, 2018 – Jun 12, 2018 · Past
Elly Ryu
Other companies: Skillz Inc. (Controller/Head of Accounting · Apr 3, 2023 – Jul 5, 2023 · Past)
Principal Accounting Officer · Apr 22, 2021 – Mar 2, 2023 · Past
Mark Sullivan
Other companies: Definium Therapeutics, Inc. (Chief Legal Officer and Corporate Secretary · Since at least Apr 13, 2023)
General Counsel & Secretary · Aug 1, 2019 – Mar 2, 2023 · Past
Monica Forbes
Other companies: Orexigen Therapeutics Inc (VP & Acting CFO · Feb 27, 2018 – Feb 27, 2018 · Past)
Chief Financial Officer · Aug 26, 2019 – Mar 2, 2023 · Past
Patricia M Drake
Other companies: Trevena, Inc. (SVP, Chief Commercial Officer · Nov 10, 2021 – Dec 14, 2023 · Past)
Chief Commercial Officer · Jun 1, 2021 – Jun 1, 2021 · Past
Thomas R Cannell
Other companies: Orexigen Therapeutics Inc (EVP, COO, Pres Global Com Prod · Mar 30, 2015 – Oct 13, 2017 · Past)
President and CEO, Director · Aug 7, 2018 – Mar 2, 2023 · Past
Glen C MacDonaldChief Technology Officer · Apr 5, 2019 – Mar 2, 2023 · Past
Kirstin AndersonPrincipal Accounting Officer · Aug 26, 2019 – Feb 19, 2021 · Past
Leslie DanDirector · Jun 12, 2018 – Jun 19, 2019 · Past
Michael A S JewettDirector · Jul 20, 2021 – Jun 22, 2022 · Past
Minori RosalesChief Development Officer · Jan 24, 2022 – Jan 24, 2022 · Past

Open People

Log in to ask 6ix AI your own questions about Sesen Bio Inc.